These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28941330)

  • 101. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation.
    Gołębiewska JE; Solomina J; Thomas C; Kijek MR; Bachul PJ; Basto L; Gołąb K; Wang LJ; Fillman N; Tibudan M; Ciepły K; Philipson L; Dębska-Ślizień A; Millis JM; Fung J; Witkowski P
    Am J Transplant; 2018 Apr; 18(4):990-997. PubMed ID: 29218834
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation.
    Anderson SJ; White MG; Armour SL; Maheshwari R; Tiniakos D; Muller YD; Berishvili E; Berney T; Shaw JAM
    Am J Transplant; 2018 Mar; 18(3):750-755. PubMed ID: 28949067
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis-related diabetes-PIM study: A multicenter phase 1-2 trial.
    Rakotoarisoa L; Wagner C; Munch M; Renaud Picard B; Grenet D; Olland A; Greget M; Enescu I; Bouilloud F; Bonnette P; Guth A; Bosco D; Mercier C; Rabilloud M; Berney T; Yves Benhamou P; Massard G; Camilo C; Colin C; Arnold C; Kessler R; Kessler L;
    Am J Transplant; 2022 Jul; 22(7):1861-1872. PubMed ID: 35403818
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control.
    Berney T; Mamin A; James Shapiro AM; Ritz-Laser B; Brulhart MC; Toso C; Demuylder-Mischler S; Armanet M; Baertschiger R; Wojtusciszyn A; Benhamou PY; Bosco D; Morel P; Philippe J
    Am J Transplant; 2006 Jul; 6(7):1704-11. PubMed ID: 16827874
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Primary Graft Function and 5 Year Insulin Independence After Pancreas and Islet Transplantation for Type 1 Diabetes: A Retrospective Parallel Cohort Study.
    Chetboun M; Masset C; Maanaoui M; Defrance F; Gmyr V; Raverdy V; Hubert T; Bonner C; Supiot L; Kerleau C; Blancho G; Branchereau J; Karam G; Chelghaf I; Houzet A; Giral M; Garandeau C; Dantal J; Le Mapihan K; Jannin A; Hazzan M; Caiazzo R; Kerr-Conte J; Vantyghem MC; Cantarovich D; Pattou F
    Transpl Int; 2023; 36():11950. PubMed ID: 38213551
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
    Malik SS; Padmanabhan D; Hull-Meichle RL
    Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Unlocking the post-transplant microenvironment for successful islet function and survival.
    Doherty DT; Khambalia HA; van Dellen D; Jennings RE; Piper Hanley K
    Front Endocrinol (Lausanne); 2023; 14():1250126. PubMed ID: 37711891
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Regenerative medicine applications: An overview of clinical trials.
    Petrosyan A; Martins PN; Solez K; Uygun BE; Gorantla VS; Orlando G
    Front Bioeng Biotechnol; 2022; 10():942750. PubMed ID: 36507264
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The challenge of HLA donor specific antibodies in the management of pancreatic islet transplantation: an illustrative case-series.
    Maanaoui M; Chetboun M; Top I; Elsermans V; Kerr-Conte J; Le Mapihan K; Defrance F; Gmyr V; Hubert T; Labalette M; Hazzan M; Vantyghem MC; Pattou F
    Sci Rep; 2022 Jul; 12(1):12463. PubMed ID: 35864198
    [TBL] [Abstract][Full Text] [Related]  

  • 111. "Old School" Islet Purification Based on the Unit Gravity Sedimentation as a Rescue Technique for Intraportal Islet Transplantation-A Case Report.
    Gołębiewska JE; Gołąb K; Gorycki T; Śledziński M; Gulczyński J; Żygowska I; Wolnik B; Hoffmann M; Witkowski P; Ricordi C; Szurowska E; Śledziński Z; Dębska-Ślizień A
    Cell Transplant; 2020; 29():963689720947098. PubMed ID: 32749147
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Advances in β-cell replacement therapy for the treatment of type 1 diabetes.
    Vantyghem MC; de Koning EJP; Pattou F; Rickels MR
    Lancet; 2019 Oct; 394(10205):1274-1285. PubMed ID: 31533905
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pancreatic ductal cells may have a negative effect on human islet transplantation.
    Marín-Cañas S; Estil Les E; Llado L; San José P; Nacher M; Téllez N; Montanya E
    PLoS One; 2019; 14(7):e0220064. PubMed ID: 31323061
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.
    Rickels MR; Robertson RP
    Endocr Rev; 2019 Apr; 40(2):631-668. PubMed ID: 30541144
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Selective Osmotic Shock for Islet Isolation in the Cadaveric Canine Pancreas.
    Thompson EM; Sollinger JL; Opara EC; Adin CA
    Cell Transplant; 2018 Mar; 27(3):542-550. PubMed ID: 29869518
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Purity of islet preparations and 5-year metabolic outcome of allogenic islet transplantation.
    Benomar K; Chetboun M; Espiard S; Jannin A; Le Mapihan K; Gmyr V; Caiazzo R; Torres F; Raverdy V; Bonner C; D'Herbomez M; Pigny P; Noel C; Kerr-Conte J; Pattou F; Vantyghem MC
    Am J Transplant; 2018 Apr; 18(4):945-951. PubMed ID: 28941330
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The potential benefit of non-purified islets preparations for islet transplantation.
    Webb MA; Dennison AR; James RF
    Biotechnol Genet Eng Rev; 2012; 28():101-14. PubMed ID: 22616483
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Rescue purification maximizes the use of human islet preparations for transplantation.
    Ichii H; Pileggi A; Molano RD; Baidal DA; Khan A; Kuroda Y; Inverardi L; Goss JA; Alejandro R; Ricordi C
    Am J Transplant; 2005 Jan; 5(1):21-30. PubMed ID: 15636608
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.